Different potencies of dihydropyridine derivatives in blocking T-type but not L-type Ca 2+ channels in neuroblastoma-glioma hybrid cells

By Stengel W.   Jainz M.   Andreas K.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 339-345

Elsevier

Access to resources Recommend Favorite

Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca 2+ channels

By Uneyama H.   Uchida H.   Konda T.   Yoshimoto R.   Akaike N.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 93-100

Elsevier

Access to resources Recommend Favorite

High-affinity binding of [ 3 H]DTZ323 to the diltiazem-binding site of L-type Ca 2+ channels

By Hagiwara M.   Adachi-Akahane S.   Nagao T.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 63-71

Elsevier

Access to resources Recommend Favorite

CP-060S interacts with three principal binding sites on the L-type Ca 2+ channel

By Suzuki Y.   Tamura K.   Adachi Y.   Fukazawa M.   Kato T.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 347-351

Elsevier

Access to resources Recommend Favorite

The binding interactions of Ro 40-5967 at the L-type Ca 2+ channel in cardiac tissue

By Rutledge A.   Triggle D.J.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite